uniquebydegrees writes: "InfoWorld is reporting about a new controversy swirling around a planned presentation at Black Hat Federal in Washington D.C. this week. Security researcher Chris Paget of IOActive will demo an RFID hacking tool that can crack HID brand door access cards. HID Corp., which makes the cards, is miffed and is accusing IOActive of patent infringement over the presentation, recalling the legal wrangling over Michael Lynn's presentation of a Cisco IOS hole at Black Hat in 2005. Black Hat's Jeff Moss says they're standing by their speaker. A news conference is scheduled for tomorrow AM. Read it here: http://www.infoworld.com/article/07/02/26/HNblackh atrfid_1.html"
sporkme writes "A scientist was frustrated when the compound she was working with (called PPAR-gamma) destroyed her sample of cancer cells. Further research revealed that the substance was surprisingly well suited as a cancer treatment. Lab test results on mice resulted in the destruction of colon tumors without making the mice sick." Quoting: "'I made a calculation error and used a lot more than I should have. And my cells died,' Schaefer said. A colleague overheard her complaining. 'The co-author on my paper said, "Did I hear you say you killed some cancer?" I said "Oh," and took a closer look.' ... [They found that the compound killed] 'pretty much every epithelial tumor cell lines we have seen.'"Update: 02/15 17:27 GMT by KD: As reader CorporalKlinger pointed out, PPAR-gamma is a cellular receptor, not a compound; and this news is not particularly new.